Sonoma Pharmaceuticals In... (SNOA)
NASDAQ: SNOA
· Real-Time Price · USD
4.02
-0.05 (-1.23%)
At close: Oct 15, 2025, 3:59 PM
4.02
0.00%
After-hours: Oct 15, 2025, 04:10 PM EDT
-1.23% (1D)
| Bid | 3.97 |
| Market Cap | 6.61M |
| Revenue (ttm) | 14.91M |
| Net Income (ttm) | -3.56M |
| EPS (ttm) | -2.21 |
| PE Ratio (ttm) | -1.82 |
| Forward PE | -3.08 |
| Analyst | n/a |
| Dividends | n/a |
| Ask | 4.12 |
| Volume | 35,174 |
| Avg. Volume (20D) | 1,264,040 |
| Open | 4.15 |
| Previous Close | 4.07 |
| Day's Range | 4.01 - 4.15 |
| 52-Week Range | 1.75 - 6.92 |
| Beta | 1.47 |
| Ex-Dividend Date | n/a |
About SNOA
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol SNOA
Website n/a
Sonoma Pharmaceuticals Inc. is scheduled to release its earnings on
Nov 6, 2025,
before market opens.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
2 months ago
+72.79%
Sonoma Pharmaceuticals shares are trading higher a...
Unlock content with
Pro Subscription
2 months ago
+1.67%
Sonoma Pharmaceuticals shares are trading higher after the company launched a HOCI-based diaper rash product in 3,600 Walmart stores and online.
2 months ago · accessnewswire.com
Sonoma Pharmaceuticals Announces Launch of Diaper Rash Product in Walmart and other U.S. ChainsBOULDER, CO / ACCESS Newswire / August 13, 2025 / Sonoma Pharmaceuticals, Inc. (Nasdaq:SNOA), a global healthcare leader developing and producing patented Microcyn® technology based stabilized hypochl...
2 months ago · accessnewswire.com
Sonoma Pharmaceuticals Reports First Fiscal Quarter 2026 Financial ResultsRevenues increased 18% compared to same period last year U.S. revenue increased 57% compared to same period last year Net loss per share decreased 43% compared to same period last year BOULDER, COLORA...